Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

InfuSystem Holdings (INFU) EBITDA (2016 - 2025)

Historic EBITDA for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to $2.2 million.

  • InfuSystem Holdings' EBITDA rose 6201.78% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 67696.79%. This contributed to the annual value of $2.4 million for FY2024, which is 40445.86% up from last year.
  • Latest data reveals that InfuSystem Holdings reported EBITDA of $2.2 million as of Q3 2025, which was up 6201.78% from $2.4 million recorded in Q2 2025.
  • InfuSystem Holdings' EBITDA's 5-year high stood at $2.4 million during Q2 2025, with a 5-year trough of -$904000.0 in Q1 2024.
  • Its 5-year average for EBITDA is $520421.1, with a median of $607000.0 in 2023.
  • Within the past 5 years, the most significant YoY rise in InfuSystem Holdings' EBITDA was 279047.62% (2023), while the steepest drop was 1570000.0% (2023).
  • InfuSystem Holdings' EBITDA (Quarter) stood at $585000.0 in 2021, then tumbled by 100.51% to -$3000.0 in 2022, then plummeted by 15700.0% to -$474000.0 in 2023, then surged by 356.54% to $1.2 million in 2024, then skyrocketed by 79.61% to $2.2 million in 2025.
  • Its EBITDA stands at $2.2 million for Q3 2025, versus $2.4 million for Q2 2025 and -$516000.0 for Q1 2025.